Cronos Group Inc. (CRON) Stock Price & Analysis
Cronos Group Inc. (CRON) rose 0.72% to USD 2.79 as of June 10, 2026 at 02:18 UTC, according to Nexqual real-time market data.
CRON last closed at USD 2.77; the session ranged USD 2.76–2.85 on volume of 1,755,542 shares. Market capitalization is $1.04B, with a 52-week range of USD 1.84–3.43 (NGM). Source: Nexqual, June 10, 2026 at 02:18 UTC.
Key Statistics (as of June 10, 2026 at 02:18 UTC)
| Price | USD 2.79 |
|---|---|
| Change | ▲ 0.72% (up) |
| Previous Close | USD 2.77 |
| Open | USD 2.78 |
| Day Range | USD 2.76 – 2.85 |
| 52-Week Range | USD 1.84 – 3.43 |
| Volume | 1,755,542 shares |
| Market Cap | $1.04B |
| Exchange | NGM |
Technical Analysis (CRON)
Nexqual's technical model rates CRON "STRONG BUY" based on 5 bullish and 0 bearish signals across 124 daily candles, as of June 10, 2026 at 02:18 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 52.37 (neutral) |
| vs SMA50 | Above (USD 2.67) |
| MACD | 0.03 (positive) |
Analyst Ratings (CRON)
Wall Street analysts rate CRON "None" based on 1 analysts, with a mean price target of USD 2.45 (range USD 2.45–2.45), per Nexqual as of June 10, 2026 at 02:18 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 2.45 |
| High Target | USD 2.45 |
| Low Target | USD 2.45 |
| Buy / Hold / Sell | 3 / 1 / 0 |
Earnings (CRON)
| Next Earnings Date | 2026-08-06 |
|---|---|
| Revenue Estimate | $60.49M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.05 vs est 0.01 ▲ beat |
| 2025-12-31 | USD 0 vs est 0.02 ▼ miss |
| 2025-09-30 | USD 0.1 vs est 0 ▲ beat |
| 2025-06-30 | USD -0.14 vs est -0.03 ▼ miss |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Financials & Fundamentals (CRON)
| Total Revenue | $159.54M |
|---|---|
| Revenue Growth (YoY) | +40.10% |
| Gross Margin | +39.61% |
| Operating Margin | -1.10% |
| Profit Margin | -1.14% |
| ROE | +0.45% |
| Debt / Equity | 0.12 |
| Current Ratio | 21.87 |
| Total Cash | $821.86M |
| Total Debt | $1.31M |
| Free Cash Flow | $-15.45M |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Financial Health Score (CRON)
Nexqual rates Cronos Group Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 02:18 UTC.
| Growth | Strong — Revenue +18% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 40%, operating -1% |
| Balance Sheet | Strong — $822M cash vs $1M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$15M, burning cash |
| Efficiency | Weak — ROE 0%, ROA -0.8% |
Ownership (CRON)
| Insider Ownership | +48.60% |
|---|---|
| Institutional Ownership | +15.77% |
| Shares Outstanding | 373.66M |
| Float | 192.24M |
| Short % of Float | +1.88% |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
Leadership (CRON)
Cronos Group Inc. is led by Michael Ryan Gorenstein (age 38), President, CEO & Chairman, per Nexqual as of June 10, 2026 at 02:18 UTC.
| President, CEO & Chairman | Michael Ryan Gorenstein (age 38) |
|---|---|
| Chief Financial Officer | Anna Shlimak (age 39) |
| Senior Director of Investor Relations & Corporate Development | Harrison Aaron |
Major Backers & Investors (CRON)
Notable institutional backers of Cronos Group Inc. include Chescapmanager LLC, Shaw D.E. & Co., Inc., Pillsbury Lake Capital LLC, according to Nexqual as of June 10, 2026 at 02:18 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Chescapmanager LLC | 2.13% |
| Shaw D.E. & Co., Inc. | 2.04% |
| Pillsbury Lake Capital LLC | 1.13% |
| Tidal Investments LLC | 1.08% |
| Amplify ETF Trust-Amplify Alternative Harvest ETF | 1.04% |
| Renaissance Technologies | 0.54% |
| Prelude Capital Management LLC | 0.4% |
| CIBC World Market, Inc. | 0.36% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Dimensional Fund Advisors | 0.9% |
Source: Nexqual, June 10, 2026 at 02:18 UTC.
From Cronos Group Inc.'s Latest SEC 10-K Filing (filed 2026-02-26)
Partnerships
- In September 2023, Cronos established a strategic partnership with Cansativa, a leading German cannabis company, to distribute PEACE NATURALS ® and LIT™ branded products along with other white-labeled cannabis products in the German medical market. • United Kingdom.
- In the second quarter of 2024, the Company entered into an amended and restated supply agreement with Cronos GrowCo (the "Cronos GrowCo Supply Agreement"), pursuant to which the Company has the right, but not the obligation, to purchase up to 70% of Cronos GrowCo's total production from the Cronos GrowCo Facility.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CGC | Canopy Growth Corporation | USD 1.02 | ▼ 0.97% |
| ACB | Aurora Cannabis Inc. | USD 3.38 | ▲ 0% |
| TLRY | Tilray Brands, Inc. | USD 5.17 | ▲ 4.66% |
| CURLD | Curaleaf Holdings, Inc. | USD 10.83 | ▼ 5.91% |
| OGI | Organigram Global Inc. | USD 1.08 | ▲ 1.89% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:18 UTC. This page is informational and not investment advice.